Melodiol Global Health (AU:ME1) has released an update.
Melodiol Global Health Limited has announced that their quoted options (ME1O) priced at $15.00 will expire on November 2, 2024, with no intention to send individual expiry notices due to the options being out of the money. The company’s shares are currently trading significantly below the exercise price, with the latest market price at $0.001, indicating a challenging period for the stock. Investors must act by the deadline if they wish to exercise their options, or they will expire worthless.
For further insights into AU:ME1 stock, check out TipRanks’ Stock Analysis page.
